SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950144-01-502161
Filing Date
2001-05-14
Accepted
2001-05-14 00:00:00
Documents
8
Period of Report
2001-03-31

Document Format Files

Seq Description Document Type Size
1 NOVEN PHARMACEUTICALS, INC. g69008e10-q.txt 10-Q 49095
2 LICENSE AGREEMENT g69008ex10-1.txt EX-10.1 48932
3 AMEND. #2 TO AMENDED & RESTATED LICENSE AGREEMENT g69008ex10-2.txt EX-10.2 23811
4 SUBLICENSE AGREEMENT g69008ex10-3.txt EX-10.3 72573
5 PURCHASE AGREEMENT g69008ex10-4.txt EX-10.4 120884
6 SUPPLY AGREEMENT g69008ex10-5.txt EX-10.5 91080
7 AMEND. MARKETING & PROMOTIONAL SERVICES AGREEMENT g69008ex10-6.txt EX-10.6 5630
8 AMENDMENT TO OPERATING AGREEMENT g69008ex10-7.txt EX-10.7 13032
  Complete submission text file 0000950144-01-502161.txt   427405
Mailing Address 11960 SW 144TH STREET MIAMI FL 33185
Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099
NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)

IRS No.: 592767632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17254 | Film No.: 1633053
SIC: 2834 Pharmaceutical Preparations